• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于乳腺癌生物标志物检测的新型颜色变化机制:萘醌作为人芳香胺 N-乙酰基转移酶 1 的特异性配体。

A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1.

机构信息

Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

出版信息

PLoS One. 2013 Aug 5;8(8):e70600. doi: 10.1371/journal.pone.0070600. Print 2013.

DOI:10.1371/journal.pone.0070600
PMID:23940600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3734253/
Abstract

Human arylamine N-acetyltransferase 1 (hNAT1) has become an attractive potential biomarker for estrogen-receptor-positive breast cancers. We describe here the mechanism of action of a selective non-covalent colorimetric biosensor for the recognition of hNAT1 and its murine homologue, mNat2, over their respective isoenzymes, leading to new opportunities in diagnosis. On interaction with the enzyme, the naphthoquinone probe undergoes an instantaneous and striking visible color change from red to blue. Spectroscopic, chemical, molecular modelling and biochemical studies reported here show that the color change is mediated by selective recognition between the conjugate base of the sulfonamide group within the probe and the conjugate acid of the arginine residue within the active site of both hNAT1 and mNat2. This represents a new mechanism for selective biomarker sensing and may be exploited as a general approach to the specific detection of biomarkers in disease.

摘要

人类芳香胺 N-乙酰基转移酶 1(hNAT1)已成为雌激素受体阳性乳腺癌有吸引力的潜在生物标志物。我们在这里描述了一种选择性非共价比色生物传感器的作用机制,用于识别 hNAT1 及其鼠同源物 mNat2,并在各自的同工酶上进行识别,从而为诊断带来了新的机会。与酶相互作用时,萘醌探针会立即发生明显的可见颜色变化,从红色变为蓝色。这里报道的光谱、化学、分子建模和生化研究表明,颜色变化是由探针中磺酰胺基团的共轭碱与 hNAT1 和 mNat2 活性位点中精氨酸残基的共轭酸之间的选择性识别介导的。这代表了一种用于选择性生物标志物传感的新机制,并可能被用作疾病中生物标志物特异性检测的一般方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/351edd7e3468/pone.0070600.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/f858c59051a5/pone.0070600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/11b95fdbbd8d/pone.0070600.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/a87925831a9e/pone.0070600.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/351edd7e3468/pone.0070600.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/f858c59051a5/pone.0070600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/11b95fdbbd8d/pone.0070600.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/a87925831a9e/pone.0070600.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cf/3734253/351edd7e3468/pone.0070600.g004.jpg

相似文献

1
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1.一种用于乳腺癌生物标志物检测的新型颜色变化机制:萘醌作为人芳香胺 N-乙酰基转移酶 1 的特异性配体。
PLoS One. 2013 Aug 5;8(8):e70600. doi: 10.1371/journal.pone.0070600. Print 2013.
2
Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1.针对假定癌症生物标志物人芳基胺N-乙酰基转移酶1的特定探针的构效关系及比色性质
Bioorg Med Chem. 2014 Jun 1;22(11):3030-54. doi: 10.1016/j.bmc.2014.03.015. Epub 2014 Mar 28.
3
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.小分子比色探针特异性检测人芳香胺 N-乙酰基转移酶 1,一种潜在的乳腺癌生物标志物。
J Am Chem Soc. 2010 Mar 17;132(10):3238-9. doi: 10.1021/ja909165u.
4
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.通过底物特异性和抑制剂结合确定的小鼠1型芳胺N - 乙酰基转移酶与人2型芳胺N - 乙酰基转移酶之间的差异。
BMC Pharmacol Toxicol. 2014 Nov 29;15:68. doi: 10.1186/2050-6511-15-68.
5
Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?人芳香胺 N-乙酰基转移酶 1:一种药物代谢酶和药物靶点?
Curr Drug Targets. 2010 Jun;11(6):759-66. doi: 10.2174/138945010791170905.
6
Allosteric regulation of arylamine N-acetyltransferase 1 by adenosine triphosphate.三磷酸腺苷对芳香胺 N-乙酰转移酶 1 的别构调节。
Biochem Pharmacol. 2018 Dec;158:153-160. doi: 10.1016/j.bcp.2018.10.013. Epub 2018 Oct 17.
7
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.潜在乳腺癌标志物人芳基胺N - 乙酰基转移酶1及其小鼠同源物小鼠芳基胺N - 乙酰基转移酶2的选择性小分子抑制剂。
Bioorg Med Chem. 2009 Jan 15;17(2):905-18. doi: 10.1016/j.bmc.2008.11.032. Epub 2008 Nov 19.
8
An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development.一种与神经元发育相关的进化上保守的N端乙酰转移酶复合物。
J Biol Chem. 2003 Oct 10;278(41):40113-20. doi: 10.1074/jbc.M301218200. Epub 2003 Jul 29.
9
Arylamine N-acetyltransferase I.芳胺N-乙酰基转移酶I
Int J Biochem Cell Biol. 2007;39(11):1999-2005. doi: 10.1016/j.biocel.2006.12.006. Epub 2007 Jan 20.
10
Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.通过定点诱变研究高度保守的精氨酸9和精氨酸64残基在人N-乙酰基转移酶NAT1和NAT2催化功能中的作用。
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):207-15. doi: 10.1042/bj3230207.

引用本文的文献

1
Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.芳胺N-乙酰基转移酶1的小分子抑制剂可减弱细胞呼吸。
ACS Pharmacol Transl Sci. 2024 Jul 17;7(8):2326-2332. doi: 10.1021/acsptsci.4c00282. eCollection 2024 Aug 9.
2
Recent advances in biosensing approaches for point-of-care breast cancer diagnostics: challenges and future prospects.用于即时护理乳腺癌诊断的生物传感方法的最新进展:挑战与未来前景
Nanoscale Adv. 2021 Aug 12;3(19):5542-5564. doi: 10.1039/d1na00453k. eCollection 2021 Sep 28.
3
Population variability of rhesus macaque (Macaca mulatta) NAT1 gene for arylamine N-acetyltransferase 1: Functional effects and comparison with human.

本文引用的文献

1
Selective Chemical Labeling of Proteins with Small Fluorescent Molecules Based on Metal-Chelation Methodology.基于金属螯合方法的蛋白质与小分子荧光分子的选择性化学标记
Sensors (Basel). 2008 Feb 19;8(2):1004-1024. doi: 10.3390/s8021004.
2
Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.芳胺N-乙酰基转移酶——从药物代谢与药物遗传学到药理学干预新靶点的鉴定
Adv Pharmacol. 2012;63:169-205. doi: 10.1016/B978-0-12-398339-8.00005-7.
3
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
恒河猴(Macaca mulatta)NAT1 基因的人群变异性:芳香胺 N-乙酰转移酶 1 的功能影响及与人的比较。
Sci Rep. 2019 Jul 29;9(1):10937. doi: 10.1038/s41598-019-47485-x.
4
Comparative analysis of xenobiotic metabolising N-acetyltransferases from ten non-human primates as in vitro models of human homologues.比较分析来自十种非人类灵长类动物的外源化学物质代谢 N-乙酰基转移酶作为人类同源物的体外模型。
Sci Rep. 2018 Jun 27;8(1):9759. doi: 10.1038/s41598-018-28094-6.
5
Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver.用夹竹桃麻素处理大鼠对肝脏中的芳胺N - 乙酰转移酶活性有显著的抑制作用。
Sci Rep. 2016 May 31;6:26906. doi: 10.1038/srep26906.
6
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.通过底物特异性和抑制剂结合确定的小鼠1型芳胺N - 乙酰基转移酶与人2型芳胺N - 乙酰基转移酶之间的差异。
BMC Pharmacol Toxicol. 2014 Nov 29;15:68. doi: 10.1186/2050-6511-15-68.
7
From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.从芳胺N-乙酰基转移酶到叶酸依赖性乙酰辅酶A水解酶:叶酸对(人类)NAT1及其同源物(小鼠)NAT2活性的影响。
PLoS One. 2014 May 13;9(5):e96370. doi: 10.1371/journal.pone.0096370. eCollection 2014.
8
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.芳香胺 N-乙酰基转移酶:从药物代谢和药物遗传学到药物发现。
Br J Pharmacol. 2014 Jun;171(11):2705-25. doi: 10.1111/bph.12598.
原发性男性乳腺癌的基因表达谱分析揭示了两个独特的亚群,并确定 N-乙酰基转移酶-1(NAT1)为一种新的预后生物标志物。
Breast Cancer Res. 2012 Feb 14;14(1):R31. doi: 10.1186/bcr3116.
4
Activity-based protein profiling: an enabling technology in chemical biology research.基于活性的蛋白质谱分析:化学生物学研究中的一项使能技术。
Curr Opin Chem Biol. 2012 Apr;16(1-2):227-33. doi: 10.1016/j.cbpa.2012.01.008. Epub 2012 Feb 8.
5
Cancer biomarkers: selecting the right drug for the right patient.癌症生物标志物:为合适的患者选择合适的药物。
Nat Rev Drug Discov. 2012 Feb 10;11(3):201-14. doi: 10.1038/nrd3651.
6
Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.芳胺N-乙酰基转移酶的新型小分子抑制剂:通过高通量筛选进行药物发现
Comb Chem High Throughput Screen. 2011 Feb;14(2):117-24. doi: 10.2174/138620711794474051.
7
Activity-based protein profiling for biochemical pathway discovery in cancer.基于活性的蛋白质谱分析在癌症生化途径发现中的应用。
Nat Rev Cancer. 2010 Sep;10(9):630-8. doi: 10.1038/nrc2901. Epub 2010 Aug 12.
8
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.小分子比色探针特异性检测人芳香胺 N-乙酰基转移酶 1,一种潜在的乳腺癌生物标志物。
J Am Chem Soc. 2010 Mar 17;132(10):3238-9. doi: 10.1021/ja909165u.
9
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.潜在乳腺癌标志物人芳基胺N - 乙酰基转移酶1及其小鼠同源物小鼠芳基胺N - 乙酰基转移酶2的选择性小分子抑制剂。
Bioorg Med Chem. 2009 Jan 15;17(2):905-18. doi: 10.1016/j.bmc.2008.11.032. Epub 2008 Nov 19.
10
The SWISS-MODEL Repository and associated resources.SWISS-MODEL 资源库及相关资源。
Nucleic Acids Res. 2009 Jan;37(Database issue):D387-92. doi: 10.1093/nar/gkn750. Epub 2008 Oct 18.